BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu C, Wang M, Xu C, Li B, Chen J, Chen J, Wang Z. Immune Checkpoint Inhibitor Therapy for Bone Metastases: Specific Microenvironment and Current Situation. J Immunol Res 2021;2021:8970173. [PMID: 34877360 DOI: 10.1155/2021/8970173] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Ihle CL, Wright-hobart SJ, Owens P. Therapeutics targeting the metastatic breast cancer bone microenvironment. Pharmacology & Therapeutics 2022;239:108280. [DOI: 10.1016/j.pharmthera.2022.108280] [Reference Citation Analysis]
2 Lian Q, Liu C, Chen F, Wang B, Wang M, Qiao S, Guan Z, Jiang S, Wang Z. Orthopedic therapeutic surgery for bone metastasis of liver cancer: Clinical efficacy and prognostic factors. Front Surg 2022;9. [DOI: 10.3389/fsurg.2022.957674] [Reference Citation Analysis]
3 Zhao J, Wang R, Sun X, Huang K, Jin J, Lan L, Jian Y, Xu Z, Wu H, Wang S, Wang J, Singh K. An Integrative Multi-Omics Analysis Based on Nomogram for Predicting Prostate Cancer Bone Metastasis Incidence. Genetics Research 2022;2022:1-17. [DOI: 10.1155/2022/8213723] [Reference Citation Analysis]
4 Litak J, Czyżewski W, Szymoniuk M, Sakwa L, Pasierb B, Litak J, Hoffman Z, Kamieniak P, Roliński J. Biological and Clinical Aspects of Metastatic Spinal Tumors. Cancers 2022;14:4599. [DOI: 10.3390/cancers14194599] [Reference Citation Analysis]
5 Cheng K, Wang Y, Chen Y, Zhu J, Qi X, Wang Y, Zou Y, Lu Q, Li Z. Multisite Radiotherapy Combined With Tislelizumab for Metastatic Castration-Resistant Prostate Cancer With Second-Line and Above Therapy Failure: Study Protocol for an Open-Label, Single-Arm, Phase Ib/II Study. Front Oncol 2022;12:888707. [DOI: 10.3389/fonc.2022.888707] [Reference Citation Analysis]
6 Del Conte A, De Carlo E, Bertoli E, Stanzione B, Revelant A, Bertola M, Spina M, Bearz A. Bone Metastasis and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Microenvironment and Possible Clinical Implications. Int J Mol Sci 2022;23:6832. [PMID: 35743275 DOI: 10.3390/ijms23126832] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Asano Y, Yamamoto N, Demura S, Hayashi K, Takeuchi A, Kato S, Miwa S, Igarashi K, Higuchi T, Yonezawa H, Araki Y, Morinaga S, Saito S, Sone T, Kasahara K, Tsuchiya H. The Therapeutic Effect and Clinical Outcome of Immune Checkpoint Inhibitors on Bone Metastasis in Advanced Non-Small-Cell Lung Cancer. Front Oncol 2022;12:871675. [DOI: 10.3389/fonc.2022.871675] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Soares do Brito J, Lopes-brás R, Abrunhosa-branquinho A, Fernandes I, Gomes I, Casimiro S, Costa L. A Tailored Approach for Appendicular Impending and Pathologic Fractures in Solid Cancer Metastases. Cancers 2022;14:893. [DOI: 10.3390/cancers14040893] [Reference Citation Analysis]